切换至 "中华医学电子期刊资源库"

中华普通外科学文献(电子版) ›› 2007, Vol. 01 ›› Issue (01) : 45 -47. doi: 10.3877/cma.j.issn.1674-0793.2007.01.014

经验医学

中下段直肠癌VEGF 表达状况与淋巴结微转移的关系
吴泽宇1, 万进1,(), 赵刚1, 姚远1, 杜嘉林1, 彭林1, 刘全芳1, 王志度1, 黄炽明1, 杨珏1   
  1. 1.510080 广东省人民医院普外三科
  • 出版日期:2007-02-20
  • 通信作者: 万进
  • 基金资助:
    广东省医学科学基金资助项目(WSTJJ2000112736580706003)

VEGF expression of middle and lower rectal carcinoma and its correlation with lymph node micrometastases

Ze-yu Wu1, Jing Wan,1(), Gang Zhao1, Yuan Yao1, Jialin Du1, Lin Peng1, Quanfang Liu1, Zhidu Wang1, Chiming Huang1, Jue Yang1   

  1. 1.Department of General Surgery,Guangdong Provincial People's Hospital,Guangzhou 510080,china
  • Published:2007-02-20
  • Corresponding author: Jing Wan
引用本文:

吴泽宇, 万进, 赵刚, 姚远, 杜嘉林, 彭林, 刘全芳, 王志度, 黄炽明, 杨珏. 中下段直肠癌VEGF 表达状况与淋巴结微转移的关系[J/OL]. 中华普通外科学文献(电子版), 2007, 01(01): 45-47.

Ze-yu Wu, Jing Wan, Gang Zhao, Yuan Yao, Jialin Du, Lin Peng, Quanfang Liu, Zhidu Wang, Chiming Huang, Jue Yang. VEGF expression of middle and lower rectal carcinoma and its correlation with lymph node micrometastases[J/OL]. Chinese Archives of General Surgery(Electronic Edition), 2007, 01(01): 45-47.

目的

分析中下段直肠癌血管内皮生长因子(VEGF)表达状况与临床病理特征的关系,初步探讨中下段直肠癌淋巴结微转移的分子机制。

方法

应用CK-20 免疫组化技术对56例中下段直肠癌患者共计661 枚淋巴结检测微转移,同时检测肿瘤组织中VEGF 表达情况。

结果

57.1%(32/56) 中下段直肠癌VEGF 表达阳性;T3 直肠癌VEGF 表达阳性率为74.1%,明显高于T2 和T1 直肠癌的43.5%和33.3%(P=0.043); 淋巴结转移阳性的中下段直肠癌VEGF 表达阳性率为72.4%,明显高于淋巴结转移阴性的40.7%(P=0.017);20 例(35.7%)中下段直肠癌患者67枚(10.1%)淋巴结检出微转移,该20 例检测出淋巴结微转移的癌组织中15 例(75%)VEGF 表达阳性,而36 例未检测出淋巴结微转移的癌组织中仅有17 例 (47.2%)VEGF 表达阳性,(P=0.044)。

结论

中下段直肠癌VEGF 表达状况与浸润深度和淋巴结转移密切相关,VEGF 可能参与中下段直肠癌淋巴结微转移的发生。

Objective

To examine the expression of VEGF of middle and lower rectal carcinoma and to evaluate its correlation with lymph node micrometastases.

Methods

661 lymph nodes from 56 patients with middle and lower rectal carcinoma who received total mesorectal excision with lymphadenetomy were detected by cytokeratin-20 IHC in addition to hematoxylin and eosin (HE)staining.The expressions of VEGF of resected primary tumors were examined by IHC.

Results

The VEGF expression was positive in 32 (57.1%) specimens.74.1% T3 tumors were examined positive VEGF expression,while only 33.3% T1 tumors and 43.5% T2 tumors were examined positive VEGF expression,P=0.043.72.4% (21/29) rectal carcinomas with positive lymph nodes were examined positive VEGF expression,while only 40.7% rectal carcinomas with negative lymph nodes were examined positive VEGF expression,P=0.017.Micrometastases were identified in 67 (10.1%) lymph nodes from 20 (35.7%) patients.The expression of VEGF was positive in 15 (75%) of the 20 patients with lymph node micrometastases,and in 17 (47.2%) of the 36 patients without lymph node micrometastases.The difference between these two groups was statistically significant (P=0.044).

Conclusion

The expression of VEGF in middle and lower rectal cancer specimens is significantly associated with depth of tumor invasion and lymph node metastasis.VEGF may play an important role in the development of lymph node micrometastases in patients with middle and lower rectal carcinoma.

表1 中下段直肠癌VEGF 表达与临床病理特征的关系
1
Ajisaka H,Miwa K.Micrometastases in sentinel nodes of gastric cancer.Br J Cancer,2003,89:676~680
2
Higashi H,Natsugoe S,Ishigami S,et al.Distribution of lymph node metastasis including micrometastasis in gastric cancer with submucosal invasion.World J Surg,2003,27:455~459
3
Karube T,Ochiai T,Shimada H,et al.Detection of sentinel lymph nodes in gastric cancers based on immunohistochemical analysis of micrometastases.J Surg Oncol,2004,87:32~38
4
Noura S,Yamamoto H,Ohnishi T,et al.Comparative detection of lymph node micrometastases of stage Ⅱcolorectal cancer by reversetranscriptasepolymerasechainreactionand immunohistochemistry.J Clin Oncol,2002,20:4232~4241
5
Matsumoto T,Ohue M,Sekimoto M,et al.Feasibility of autonomic nerve-preserving surgery for advanced rectal cancer based on analysis of micrometastases.Br J Surg,2005,92:1444~1448
6
Guba M,Seeliger H,Kleespies A,et al.Vascular endothelial growth factor in colorectal cancer.Int J Colorectal Dis,2004,19:510~517
7
Schmitz V,Kornek M,Hilbert T,et al.Treatment of metastatic colorectal carcinomas by systemic inhibition of vascular endothelial growth factor signaling in mice.World J Gastroenterol,2005,11:4332~4336
8
Ferroni P,Spila A,Martini F,et al.Prognostic value of vascular endothelial growth factor tumor tissue content of colorectal cancer.Oncology,2005,69:145~153
9
Onogawa S,Kitadai Y,Tanaka S,et al.Expression of VEGF-C and VEGF-D at the invasive edge correlates with lymph node metastasis and prognosis of patients with colorectal carcinoma.Cancer Sci,2004,95:32~39
10
Kawakami M,Furuhata T,Kimura Y,et al.Quantification of vascular endothelial growth factor-C and its receptor-3 messenger RNA with real-time quantitative polymerase chain reaction as a predictor of lymph node metastasis in human colorectal cancer.Surgery,2003,133:300~308
11
Ochs AM,Wong L,Kakani V,et al.Expression of vascular endothelial growth factor and HER2/neu in stage Ⅱ colon cancer and correlation with survival.Clin Colorectal Cancer,2004,4:262~267
12
Kazama S,Kitayama J,Watanabe T,et al.Expression pattern of vascular endothelial growth factor-C in human colorectal normal mucosa and neoplastic mucosa.Hepatogastroenterology,2004,51:391~395
13
Uner A,Ebinc FA,Akyurek N,et al.Vascular endothelial growth factor,c-erbB-2 and c-erbB-3 expression in colorectal adenoma and adenocarcinoma.Exp Oncol,2005,27:225~228
14
Maeda K,Yashiro M,Nishihara T,et al.Correlation between vascular endothelial growth factor C expression and lymph node metastasis in T1 carcinoma of the colon and rectum.Surg Today,2003,33:736~739
15
Kawakami M,Furuhata T,Kimura Y,et al.Expression analysis of vascular endothelial growth factors and their relationships to lymph node metastasis in human colorectal cancer.J Exp Clin Cancer Res,2003,22:229~237
16
Palma RT,Waisberg J,Bromberg SH,et al.Micrometastasis in regional lymph nodes of extirpated colorectal carcinoma:immunohistochemical study using anti-cytokeratin antibodies AE1/AE3.Colorectal Dis,2003,5:164~168
17
Takayama O,Yamamoto H,Ikeda K,et al.Application of RTPCR to clinical diagnosis of micrometastasis of colorectal cancer:A translational research study.Int J Oncol,2004,25:597~604
[1] 李朝阳, 任文琦, 侯令密, 蒋燕清, 刘沁豪, 赵永真, 张梅, 钱双强, 李金穗. T1-2N1miM0期乳腺癌患者乳房切除术后前哨淋巴结微转移的处理[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(02): 85-92.
[2] 邵小丽, 林燕, 张玲玲, 韩亚琴. 超声引导下子宫肌瘤注射聚桂醇硬化术联合术后米非司酮治疗临床疗效分析[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(03): 353-360.
[3] 王博, 白子锐, 李坚. 近红外二区新型血管内皮生长因子受体靶向探针在结直肠癌小鼠模型中的应用[J/OL]. 中华普通外科学文献(电子版), 2023, 17(03): 173-177.
[4] 黄福, 王黔, 金相任, 唐云川. VEGFR2、miR-27a-5p在胃癌组织中的表达与临床病理参数及预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 558-561.
[5] 朱佳琳, 方向, 贵诗雨, 黄丹, 周小雨, 郭文恺. 大鼠切口疝腹膜前间隙补片修补术后血清中VEGF 和Ang-1 的表达情况[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 703-707.
[6] 张敏龙, 杨翠平, 王博, 崔云杰, 金发光. MiR-200b-3p 通过抑制HIF-1α 表达减轻海水吸入诱导的肺水肿作用及机制[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 696-700.
[7] 暴静, 吴霞, 田雅萍, 尹钢. 维生素D3联合孟鲁司特钠治疗支气管哮喘对血清VEGF、TGF-β1及肺功能的影响[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(01): 63-67.
[8] 庞丹, 孙刚, 伊乐, 丁立云, 钟美艳, 张杰, 于婷婷, 郭乐峰. 血清HIF-1α、VEGF、Flt-1的检测对ARDS的预后及临床意义[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(01): 127-130.
[9] 芦丹, 杨硕, 刘旭. VEGF、HMGB1、hs-CRP/Alb在AECOPD伴呼吸衰竭中的变化及预后分析[J/OL]. 中华肺部疾病杂志(电子版), 2023, 16(04): 532-534.
[10] 朱迎, 赵征, 许达, 陆录, 殷保兵. 免疫检查点抑制剂治疗肝细胞癌的进展与展望[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(01): 5-10.
[11] 刘涵, 沈强, 张蓝月, 陈健. 糖尿病视网膜病变分子生物标志物的研究进展[J/OL]. 中华眼科医学杂志(电子版), 2023, 13(06): 376-380.
[12] 杨金涓, 夏建平. 糖尿病性黄斑水肿患者基线房水细胞因子水平评估血管内皮生长因子疗效的临床研究[J/OL]. 中华眼科医学杂志(电子版), 2023, 13(06): 350-355.
[13] 宋建波, 韩俊伟, 周敏, 温红萍. 血管内皮生长因子受体酪氨酸激酶抑制剂致蛋白尿风险的荟萃分析[J/OL]. 中华临床医师杂志(电子版), 2023, 17(12): 1297-1303.
[14] 吴晓翔, 杨波, 李景漩, 张凤玲, 郭桂辉, 郑少培. 脐动脉超声检查联合NLR、sFlt-1/PLGF对妊娠高血压综合征患者不良妊娠结局的预测价值[J/OL]. 中华临床医师杂志(电子版), 2023, 17(03): 266-271.
[15] 颜凡辉, 赵明俐, 李颖, 郭方明, 詹景冬, 赵英杰, 王阳, 张艳芬, 赵笑梅. 急性冠脉综合征患者冠脉血管病变程度与血清TNF-α、VEGF水平相关性研究[J/OL]. 中华诊断学电子杂志, 2023, 11(03): 158-164.
阅读次数
全文


摘要